PI3 and irritable bowel syndrome: The biomarkers assessed in this study (NE, elafin, NE/elafin ratio) were selected based on their active role in key processes related to the pathogenesis of IBD, including intestinal barrier disruption, excessive immune response, and intestinal tissue damage.